Mira Pharmaceuticals Analyst Ratings
BenzingaOct 1 00:53
Rodman & Renshaw Initiates Coverage On Mira Pharmaceuticals With Buy Rating, Announces Price Target of $17
BenzingaAug 5 18:17
No Data